Dedicated to the Development of Novel Biotherapeutics

An Integral Part of the Pharmaceutical Community Since 2009

A Respected & Trusted Biotherapeutics Company

Welcome to Zyngenia Inc.—a biotherapeutics company that is focused on developing a new class of biotherapeutics to address the complexity of diseases by simultaneously targeting multiple biological pathways. Learn More.

Cancer Cell

Contact us today to learn more about our patents. (301) 453-0100

Our Endeavors & Objectives

Here at Zyngenia Inc., our experts:

Develop smartly engineered monoclonal antibody-based therapeutics, thereby creating opportunities for new biologic activities by the simultaneous targeting of multiple pathways.

Address unmet needs in the treatment of cancer, inflammation, and autoimmune disorders

Develop enhanced and more comprehensive disease intervention with the cost and development paradigm of a single biologic agent.